Cite

HARVARD Citation

    Hussaini, S. et al. (n.d.). Price variability of pembrolizumab across U.S. National Cancer Institute–designated Cancer Centers (NCICCs) from 2016-2021.. Journal of clinical oncology. 40 (28), p. 48. [Online]. 
  
Back to record